StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report issued on Wednesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Price Performance Shares of SRNE opened at $0.00 on Wednesday. Sorrento Therapeutics has a 1 year low of $0.00 and a 1 year […]